Month defined as 1 bottle of 30 tablets of Wegovy
Los nuevos medicamentos contra la obesidad reducen hasta un 20% el riesgo de infarto e ictus La farmacutica Novo Nordisk, fabricante de Ozempic y Wegovy, asegura que estas drogas minimizan las enfermedades cardiovasculares en personas con sobrepeso Las nuevas drogas contra la obesidad reducen el riesgo de infartos e ictus hasta en un 20% en personas con sobrepeso
So maybe, initially, you know, meeting with a dietitian might be most appropriate and, you know, at some point, you know, if if that is addressed, if the if the exercise is addressed, you know, maybe maybe that is a appropriate time to engage a prescriber and and look at drug treatment depending on the the target, you know, targets that are set by the care team and and the patient and what they need to ultimately, you know, live a healthier life and and, you know, reduce the likelihood of progressing to diabetes or some of those other comorbid or or, you know, complications associated with obesity down the road
Certain people shouldn't take it: -Pregnant or breastfeeding women -People with a history of pancreatitis -People with Type-1 diabetes -People with an allergy to semaglutide (or any of its ingredients) -People with Multiple Endocrine Neoplasia syndrome type 2 Always consult a medical professional before taking semaglutide
